Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemia

被引:61
作者
Westers, TM
Stam, AGM
Scheper, RJ
Regelink, JC
Nieuwint, AWM
Schuurhuis, GJ
van de Loosdrecht, AA
Ossenkoppele, GJ
机构
[1] Vrije Univ Amsterdam, Med Ctr, Dept Haematol, NL-1081 HV Amsterdam, Netherlands
[2] VU Univ, Med Ctr, Dept Pathol, Amsterdam, Netherlands
[3] VU Univ, Med Ctr, Dept Clin Genet & Human Genet, Amsterdam, Netherlands
关键词
acute myeloid leukaemia; A23187; calcium ionophore; cytotoxicity; dendritic cell;
D O I
10.1007/s00262-002-0316-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The ability of acute myeloid leukaemia (AML) cells to acquire dendritic cell (DC)-like characteristics in vitro with a rapid culture method based either on the phorbol ester PMA or calcium ionophores has been studied in comparison to conventional AML-DC cultures with the cytokines granulocyte-macrophage colony-stimulating factor (GM-CSF), tumour necrosis factor-alpha (TNF-alpha), interleukin-3 (IL-3), SCF, FLT3-L and IL-4. In all AML patients, antigen-presenting cells (APC) could be generated from leukaemic cells in 2 days by incubation with PMA or calcium ionophore (A23187 or ionomycin) in the presence as well as in the absence of IL-4. In 30 out of 36 patients APC could be generated after 2 weeks of culture in cytokine-enriched medium. AML-APC cultured with PMA or calcium ionophores immunophenotypically and functionally were at a more mature stage than those cultured in cytokine-enriched medium. The most mature APC were generated by calcium ionophore A23187 plus IL-4, as evidenced by the higher expression of CD40, CD80, CD86 and HLA-DR. Autologous T cell mediated cytotoxicity towards AML blast cells in vitro was observed in 2 cases tested. The persistence of cytogenetic abnormalities confirmed the leukaemic origin of the AML-APC. The generation of AML-APC was possible from freshly isolated as well as cryopreserved material. Our data show that generation of sufficient AML-APC by A23187 plus IL-4 is feasible, for vaccination purposes, in approximately 70% of AML specimens, offering a time-saving and cost-effective approach in preparing anti-leukaemia vaccines.
引用
收藏
页码:17 / 27
页数:11
相关论文
共 39 条
[1]   Long-term culture of human CD34+ progenitors with FLT3-ligand, thrombopoietin, and stem cell factor induces extensive amplification of a CD34-CD14- and a CD34-CD14+ dendritic cell precursor [J].
Arrighi, JF ;
Hauser, C ;
Chapuis, B ;
Zubler, RH ;
Kindler, V .
BLOOD, 1999, 93 (07) :2244-2252
[2]   The generation of dendritic-like cells with increased allostimulatory function from acute myeloid leukemia cells of various FAB subclasses [J].
Brouwer, RE ;
van der Hoorn, M ;
Kluin-Nelemans, HC ;
van Zelderen-Bhola, S ;
Willemze, R ;
Falkenburg, JHF .
HUMAN IMMUNOLOGY, 2000, 61 (06) :565-574
[3]   GM-CSF AND TNF-ALPHA COOPERATE IN THE GENERATION OF DENDRITIC LANGERHANS CELLS [J].
CAUX, C ;
DEZUTTERDAMBUYANT, C ;
SCHMITT, D ;
BANCHEREAU, J .
NATURE, 1992, 360 (6401) :258-261
[4]  
Charbonnier A, 1999, EUR J IMMUNOL, V29, P2567, DOI 10.1002/(SICI)1521-4141(199908)29:08<2567::AID-IMMU2567>3.0.CO
[5]  
2-S
[6]   Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses [J].
Choudhury, A ;
Liang, JC ;
Thomas, EK ;
Flores-Romo, L ;
Xie, QS ;
Agusala, K ;
Sutaria, S ;
Sinha, I ;
Champlin, RE ;
Claxton, DF .
BLOOD, 1999, 93 (03) :780-786
[7]   Human leukemia-derived dendritic cells: Ex-vivo development of specific antileukemic cytotoxicity [J].
Choudhury, A ;
Toubert, A ;
Sutaria, S ;
Charron, D ;
Champlin, RE ;
Claxton, DF .
CRITICAL REVIEWS IN IMMUNOLOGY, 1998, 18 (1-2) :121-131
[8]   Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia [J].
Choudhury, A ;
Gajewski, JL ;
Liang, JC ;
Popat, U ;
Claxton, DF ;
Kliche, KO ;
Andreeff, M ;
Champlin, RE .
BLOOD, 1997, 89 (04) :1133-1142
[9]   CD34+ acute myeloid and lymphoid leukemic blasts can be induced to differentiate into dendritic cells [J].
Cignetti, A ;
Bryant, E ;
Allione, B ;
Vitale, A ;
Foa, R ;
Cheever, MA .
BLOOD, 1999, 94 (06) :2048-2055
[10]   Stem cell factor and FLT3-ligand are strictly required to sustain the long-term expansion of primitive CD34+DR- dendritic cell precursors [J].
Curti, A ;
Fogli, M ;
Ratta, M ;
Tura, S ;
Lemoli, RM .
JOURNAL OF IMMUNOLOGY, 2001, 166 (02) :848-854